MIR4503

Q-omics provides the consensus-scored MIR4503 profile across patient tissues and cancer cell-line models. MIR4503 expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in LUAD. Additionally, MIR4503 RNA expression shows 5,676 significant gene co-expression associations, with the highest sampling consensus in UCEC. Together, these results highlight LUAD, and UCEC as cancer lineages where MIR4503 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes MIR4503 survival associations across molecular data types. MIR4503 RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MIR4503 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	LUAD (27)	view →

This table ranks reproducible MIR4503 RNA expression–survival associations across cancer types. High MIR4503 expression shows unfavorable associations in LUAD and KIRP. The LUAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .007). Together, the overview and detailed table identify LUAD as the clearest survival context for MIR4503 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.221	0.767	.007	27	view →
KIRP	DFS	Tertile	All	0.183	0.610	.029	21	view →

Pink = unfavorable, green = favorable. all 2 lineages →

MIR4503-LUAD (DFS)

Explore this curve interactively →